{
  "DOI": "10.1007/s10689-020-00224-y",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-020-00224-y",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eA substantial proportion of pathogenic variants associated with an increased risk of hereditary cancer are sequence variants affecting RNA splicing. The classification of these variants can be complex when both non-functional and functional transcripts are produced from the variant allele. We present four \u003cjats:italic\u003eBRCA2\u003c/jats:italic\u003e splice site variants with complex variant interpretations (\u003cjats:italic\u003eBRCA2\u003c/jats:italic\u003e c.68-3T\u0026gt;G, c.68-2A\u0026gt;G, c.425G\u0026gt;T, c.8331+2T\u0026gt;C). Evidence supporting a pathogenic classification is available for each variant, including in silico models, absence in population databases, and published functional data. However, comprehensive RNA analysis showed that some functional transcript may be produced by each variant. \u003cjats:italic\u003eBRCA2\u003c/jats:italic\u003e c.68-3T\u0026gt;G results in a partial splice defect. For \u003cjats:italic\u003eBRCA2\u003c/jats:italic\u003e c.68-2A\u0026gt;G and c.425G\u0026gt;T, aberrant splicing was shown to produce a potentially functional, in-frame transcript. \u003cjats:italic\u003eBRCA2\u003c/jats:italic\u003e c.8331+2T\u0026gt;C may utilize a functional GC donor in place of the wild-type GT donor. The severity of cancer history for carriers of these variants was also assessed using a history weighting algorithm and was not consistent with pathogenic controls (carriers of known pathogenic variants in \u003cjats:italic\u003eBRCA2\u003c/jats:italic\u003e). Due to the conflicting evidence, our laboratory classifies these \u003cjats:italic\u003eBRCA2\u003c/jats:italic\u003e variants as variants of uncertain significance. This highlights the importance of evaluating new and existing evidence to ensure accurate variant classification and appropriate patient care.\u003c/jats:p\u003e",
  "alternative-id": [
    "224"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "8 June 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "15 December 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "20 January 2021"
    },
    {
      "group": {
        "label": "Compliance with Ethical Standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "All authors were employed by Myriad Genetics, Inc. at the time of this study."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-9257-3724",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Nix",
      "given": "Paola",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Mundt",
      "given": "Erin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Coffee",
      "given": "Bradford",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Goossen",
      "given": "Elizabeth",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Warf",
      "given": "Bryan M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Brown",
      "given": "Krystal",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bowles",
      "given": "Karla",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Roa",
      "given": "Benjamin",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        1,
        20
      ]
    ],
    "date-time": "2021-01-20T03:02:36Z",
    "timestamp": 1611111756000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        1,
        28
      ]
    ],
    "date-time": "2022-01-28T11:27:13Z",
    "timestamp": 1643369233000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        12,
        13
      ]
    ],
    "date-time": "2022-12-13T13:11:08Z",
    "timestamp": 1670937068212
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2021,
        1,
        20
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2022,
          1
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            1,
            20
          ]
        ],
        "date-time": "2021-01-20T00:00:00Z",
        "timestamp": 1611100800000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            1,
            20
          ]
        ],
        "date-time": "2021-01-20T00:00:00Z",
        "timestamp": 1611100800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-020-00224-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-020-00224-y/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-020-00224-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "7-19",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2021,
        1,
        20
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        1,
        20
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        1
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "224_CR1",
      "unstructured": "Daly MB et al (2020) NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic (Version 1.2020). NCCN Clinical Practice Guidelines in Oncology 2020 December 4, 2019 January 14, 2020]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf"
    },
    {
      "DOI": "10.1042/CS20160211",
      "author": "D Baralle",
      "doi-asserted-by": "publisher",
      "first-page": "355",
      "issue": "5",
      "journal-title": "Clin Sci",
      "key": "224_CR2",
      "unstructured": "Baralle D, Buratti E (2017) RNA splicing in human disease and in the clinic. Clin Sci 131(5):355–368",
      "volume": "131",
      "year": "2017"
    },
    {
      "DOI": "10.3389/fgene.2018.00366",
      "author": "A Moles-Fernandez",
      "doi-asserted-by": "publisher",
      "first-page": "366",
      "journal-title": "Front Genet",
      "key": "224_CR3",
      "unstructured": "Moles-Fernandez A et al (2018) Computational tools for splicing defect prediction in breast/ovarian cancer genes: how efficient are they at predicting RNA alterations? Front Genet 9:366",
      "volume": "9",
      "year": "2018"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "issue": "5",
      "journal-title": "Genet Med",
      "key": "224_CR4",
      "unstructured": "Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1002/humu.23882",
      "author": "G Montalban",
      "doi-asserted-by": "publisher",
      "first-page": "2296",
      "issue": "12",
      "journal-title": "Hum Mutat",
      "key": "224_CR5",
      "unstructured": "Montalban G et al (2019) Incorporation of semi-quantitative analysis of splicing alterations for the clinical interpretation of variants in BRCA1 and BRCA2 genes. Hum Mutat 40(12):2296–2317",
      "volume": "40",
      "year": "2019"
    },
    {
      "DOI": "10.1002/path.5268",
      "author": "E Fraile-Bethencourt",
      "doi-asserted-by": "publisher",
      "first-page": "409",
      "issue": "4",
      "journal-title": "J Pathol",
      "key": "224_CR6",
      "unstructured": "Fraile-Bethencourt E et al (2019) Mis-splicing in breast cancer: identification of pathogenic BRCA2 variants by systematic minigene assays. J Pathol 248(4):409–420",
      "volume": "248",
      "year": "2019"
    },
    {
      "DOI": "10.1002/ijc.32114",
      "author": "RD Brandao",
      "doi-asserted-by": "publisher",
      "first-page": "401",
      "issue": "2",
      "journal-title": "Int J Cancer",
      "key": "224_CR7",
      "unstructured": "Brandao RD et al (2019) Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes. Int J Cancer 145(2):401–414",
      "volume": "145",
      "year": "2019"
    },
    {
      "DOI": "10.1001/jamanetworkopen.2019.13900",
      "author": "R Karam",
      "doi-asserted-by": "publisher",
      "issue": "10",
      "journal-title": "JAMA Netw Open",
      "key": "224_CR8",
      "unstructured": "Karam R et al (2019) Assessment of diagnostic outcomes of RNA genetic testing for hereditary cancer. JAMA Netw Open 2(10):e1913900",
      "volume": "2",
      "year": "2019"
    },
    {
      "DOI": "10.3389/fonc.2018.00140",
      "author": "VL Lattimore",
      "doi-asserted-by": "publisher",
      "first-page": "140",
      "journal-title": "Front Oncol",
      "key": "224_CR9",
      "unstructured": "Lattimore VL et al (2018) Investigation of experimental factors that underlie BRCA1/2 mRNA isoform expression variation: recommendations for utilizing targeted rna sequencing to evaluate potential spliceogenic variants. Front Oncol 8:140",
      "volume": "8",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41698-020-0109-y",
      "author": "T Landrith",
      "doi-asserted-by": "publisher",
      "first-page": "4",
      "journal-title": "NPJ Precis Oncol",
      "key": "224_CR10",
      "unstructured": "Landrith T et al (2020) Splicing profile by capture RNA-seq identifies pathogenic germline variants in tumor suppressor genes. NPJ Precis Oncol 4:4",
      "volume": "4",
      "year": "2020"
    },
    {
      "key": "224_CR11",
      "unstructured": "Evidence-based Network for the Interpretation of Germline Mutant Alleles. ENIGMA BRCA1/2 Gene Variant Classification Criteria 2017 9/1/2020]; Available from: https://enigmaconsortium.org/library/general-documents/enigma-classification-criteria/"
    },
    {
      "DOI": "10.1016/j.molcel.2006.05.022",
      "author": "B Xia",
      "doi-asserted-by": "publisher",
      "first-page": "719",
      "issue": "6",
      "journal-title": "Mol Cell",
      "key": "224_CR12",
      "unstructured": "Xia B et al (2006) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 22(6):719–729",
      "volume": "22",
      "year": "2006"
    },
    {
      "DOI": "10.1093/nar/gkl535",
      "author": "I Vorechovsky",
      "doi-asserted-by": "publisher",
      "first-page": "4630",
      "issue": "16",
      "journal-title": "Nucleic Acids Res",
      "key": "224_CR13",
      "unstructured": "Vorechovsky I (2006) Aberrant 3′ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization. Nucleic Acids Res 34(16):4630–4641",
      "volume": "34",
      "year": "2006"
    },
    {
      "DOI": "10.1038/embor.2009.126",
      "author": "AW Oliver",
      "doi-asserted-by": "publisher",
      "first-page": "990",
      "issue": "9",
      "journal-title": "EMBO Rep",
      "key": "224_CR14",
      "unstructured": "Oliver AW et al (2009) Structural basis for recruitment of BRCA2 by PALB2. EMBO Rep 10(9):990–996",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1371/journal.pgen.1006691",
      "author": "E Fraile-Bethencourt",
      "doi-asserted-by": "publisher",
      "issue": "3",
      "journal-title": "PLoS Genet",
      "key": "224_CR15",
      "unstructured": "Fraile-Bethencourt E et al (2017) Functional classification of DNA variants by hybrid minigenes: identification of 30 spliceogenic variants of BRCA2 exons 17 and 18. PLoS Genet 13(3):e1006691",
      "volume": "13",
      "year": "2017"
    },
    {
      "DOI": "10.1093/hmg/ddw066",
      "author": "E Thirthagiri",
      "doi-asserted-by": "publisher",
      "first-page": "1934",
      "issue": "10",
      "journal-title": "Hum Mol Genet",
      "key": "224_CR16",
      "unstructured": "Thirthagiri E et al (2016) BRCA2 minor transcript lacking exons 4-7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutation. Hum Mol Genet 25(10):1934–1945",
      "volume": "25",
      "year": "2016"
    },
    {
      "DOI": "10.1002/humu.23818",
      "author": "MT Parsons",
      "doi-asserted-by": "publisher",
      "first-page": "1557",
      "issue": "9",
      "journal-title": "Hum Mutat",
      "key": "224_CR17",
      "unstructured": "Parsons MT et al (2019) Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification. Hum Mutat 40(9):1557–1578",
      "volume": "40",
      "year": "2019"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-20-0895",
      "author": "H Tubeuf",
      "doi-asserted-by": "publisher",
      "first-page": "3593",
      "issue": "17",
      "journal-title": "Cancer Res",
      "key": "224_CR18",
      "unstructured": "Tubeuf H et al (2020) Calibration of pathogenicity due to variant-induced leaky splicing defects by using BRCA2 exon 3 as a model system. Cancer Res 80(17):3593–3605",
      "volume": "80",
      "year": "2020"
    },
    {
      "DOI": "10.1038/ejhg.2017.116",
      "author": "G Davy",
      "doi-asserted-by": "publisher",
      "first-page": "1147",
      "issue": "10",
      "journal-title": "Eur J Hum Genet",
      "key": "224_CR19",
      "unstructured": "Davy G et al (2017) Detecting splicing patterns in genes involved in hereditary breast and ovarian cancer. Eur J Hum Genet 25(10):1147–1154",
      "volume": "25",
      "year": "2017"
    },
    {
      "DOI": "10.1136/jmedgenet-2015-103570",
      "author": "JD Fackenthal",
      "doi-asserted-by": "publisher",
      "first-page": "548",
      "issue": "8",
      "journal-title": "J Med Genet",
      "key": "224_CR20",
      "unstructured": "Fackenthal JD et al (2016) Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples. J Med Genet 53(8):548–558",
      "volume": "53",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s10549-011-1599-7",
      "author": "RD Brandao",
      "doi-asserted-by": "publisher",
      "first-page": "971",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "224_CR21",
      "unstructured": "Brandao RD et al (2011) Characterisation of unclassified variants in the BRCA1/2 genes with a putative effect on splicing. Breast Cancer Res Treat 129(3):971–982",
      "volume": "129",
      "year": "2011"
    },
    {
      "DOI": "10.1182/blood-2010-12-324541",
      "author": "K Biswas",
      "doi-asserted-by": "publisher",
      "first-page": "2430",
      "issue": "9",
      "journal-title": "Blood",
      "key": "224_CR22",
      "unstructured": "Biswas K et al (2011) A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay. Blood 118(9):2430–2442",
      "volume": "118",
      "year": "2011"
    },
    {
      "DOI": "10.3390/cancers11030295",
      "author": "E Gelli",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Cancers",
      "key": "224_CR23",
      "unstructured": "Gelli E et al (2019) Usefulness and limitations of comprehensive characterization of mRNA splicing profiles in the definition of the clinical relevance of BRCA1/2 variants of uncertain significance. Cancers 11:3",
      "volume": "11",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s13053-019-0113-9",
      "author": "T Wangensteen",
      "doi-asserted-by": "publisher",
      "first-page": "14",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "224_CR24",
      "unstructured": "Wangensteen T et al (2019) Diagnostic mRNA splicing assay for variants in BRCA1 and BRCA2 identified two novel pathogenic splicing aberrations. Hered Cancer Clin Pract 17:14",
      "volume": "17",
      "year": "2019"
    },
    {
      "DOI": "10.1001/jama.2018.13152",
      "author": "J Mersch",
      "doi-asserted-by": "publisher",
      "first-page": "1266",
      "issue": "12",
      "journal-title": "JAMA",
      "key": "224_CR25",
      "unstructured": "Mersch J et al (2018) Prevalence of variant reclassification following hereditary cancer genetic testing. JAMA 320(12):1266–1274",
      "volume": "320",
      "year": "2018"
    },
    {
      "DOI": "10.1002/humu.23411",
      "author": "M Colombo",
      "doi-asserted-by": "publisher",
      "first-page": "729",
      "issue": "5",
      "journal-title": "Hum Mutat",
      "key": "224_CR26",
      "unstructured": "Colombo M et al (2018) The BRCA2 c.68-7T \u003e A variant is not pathogenic: a model for clinical calibration of spliceogenicity. Hum Mutat 39(5):729–741",
      "volume": "39",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41436-020-0814-5",
      "author": "RLS Mesman",
      "doi-asserted-by": "publisher",
      "first-page": "1355",
      "issue": "8",
      "journal-title": "Genet Med",
      "key": "224_CR27",
      "unstructured": "Mesman RLS et al (2020) Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2. Genet Med 22(8):1355–1365",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1093/hmg/ddw094",
      "author": "M de la Hoya",
      "doi-asserted-by": "publisher",
      "first-page": "2256",
      "issue": "11",
      "journal-title": "Hum Mol Genet",
      "key": "224_CR28",
      "unstructured": "de la Hoya M et al (2016) Combined genetic and splicing analysis of BRCA1 c.[594-2A\u003eC; 641A\u003eG] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. Hum Mol Genet 25(11):2256–2268",
      "volume": "25",
      "year": "2016"
    },
    {
      "DOI": "10.1093/nar/gku744",
      "author": "GE Parada",
      "doi-asserted-by": "publisher",
      "first-page": "10564",
      "issue": "16",
      "journal-title": "Nucleic Acids Res",
      "key": "224_CR29",
      "unstructured": "Parada GE et al (2014) A comprehensive survey of non-canonical splice sites in the human transcriptome. Nucleic Acids Res 42(16):10564–10578",
      "volume": "42",
      "year": "2014"
    },
    {
      "DOI": "10.1002/humu.23626",
      "author": "AN Abou Tayoun",
      "doi-asserted-by": "publisher",
      "first-page": "1517",
      "issue": "11",
      "journal-title": "Hum Mutat",
      "key": "224_CR30",
      "unstructured": "Abou Tayoun AN et al (2018) Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion. Hum Mutat 39(11):1517–1524",
      "volume": "39",
      "year": "2018"
    },
    {
      "DOI": "10.1002/humu.23821",
      "author": "JH Lin",
      "doi-asserted-by": "publisher",
      "first-page": "1856",
      "issue": "10",
      "journal-title": "Hum Mutat",
      "key": "224_CR31",
      "unstructured": "Lin JH et al (2019) First estimate of the scale of canonical 5′ splice site GT\u003eGC variants capable of generating wild-type transcripts. Hum Mutat 40(10):1856–1873",
      "volume": "40",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s10549-014-3065-9",
      "author": "D Pruss",
      "doi-asserted-by": "publisher",
      "first-page": "119",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "224_CR32",
      "unstructured": "Pruss D et al (2014) Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes. Breast Cancer Res Treat 147(1):119–132. https://doi.org/10.1007/s10549-014-3065-9",
      "volume": "147",
      "year": "2014"
    },
    {
      "DOI": "10.1093/nar/gkl556",
      "doi-asserted-by": "crossref",
      "key": "224_CR33",
      "unstructured": "Sheth N, Roca X, Hastings ML, Roeder T, Krainer AR, Sachidanandam R (2006) Comprehensive splice-site analysis using comparative genomics. Nucleic Acids Res 34(14):3955–3967"
    }
  ],
  "reference-count": 33,
  "references-count": 33,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-020-00224-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Interpretation of BRCA2 Splicing Variants: A Case Series of Challenging Variant Interpretations and the Importance of Functional RNA Analysis"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "21"
}